German industry talks suggest stakeholder role
This article was originally published in Clinica
Executive Summary
Against the backdrop of structural change for the healthcare economy in Germany, device industry association (BVMed) chairman Anton Schmidt has held a second annual round of bilaterals with hospital directors association (VKD) head Heinz Kolking in a bid to assess where co-operation is necessary. Meeting in Berlin last month, the association heads agreed that they should be ready to co-operate at a political level on areas of common interest. The VKD asked industry to provide more support to clinics in order to improve services. In view of the advent of the DRGs, it is increasingly necessary for industry to play a bigger role in not just the provision of products, but also to become a bigger stakeholder in the entire provision of services surrounding their products, the association suggested.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.